Yuta Ohgi
Otsuka (Japan)(JP)Ono Pharmaceutical (Japan)(JP)
Publications by Year
Research Areas
Neurotransmitter Receptor Influence on Behavior, Treatment of Major Depression, Stress Responses and Cortisol, Receptor Mechanisms and Signaling, Tryptophan and brain disorders
Most-Cited Works
- → Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration(2012)206 cited
- → Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis(2016)110 cited
- → Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation(2016)68 cited
- → Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling(2016)58 cited
- → Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success(2015)45 cited
- → Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: A role for serotonin 5-HT1A receptors(2014)39 cited
- → Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin–dopamine activity modulator: A role for serotonin 5-HT1A and 5-HT2A receptors(2015)37 cited
- → Brexpiprazole has a low risk of dopamine D2 receptor sensitization and inhibits rebound phenomena related to D2 and serotonin 5‐HT2A receptors in rats(2019)24 cited
- → Increased BDNF-TrkB signaling in the nucleus accumbens plays a role in the risk for psychosis after cannabis exposure during adolescence(2019)10 cited
- → Alterations in amino acid levels in mouse brain regions after adjunctive treatment of brexpiprazole with fluoxetine: comparison with (R)-ketamine(2017)9 cited